Dana Farber Cancer Institute (Data Collection Only) — Boston, Massachusetts

Dana Farber Cancer Institute (Data Collection Only) is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute (Data Collection Only) has participated in 7 clinical trials with 7 currently active.

Therapeutic areas: Primary Extra-cranial Solid Tumor, Recurrent or Refractory Glypican 3 (GPC3), T-cell Lymphoma.

Sponsors: Memorial Sloan Kettering Cancer Center.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute (Data Collection Only)?

Dana Farber Cancer Institute (Data Collection Only) has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute (Data Collection Only) conducted?

Dana Farber Cancer Institute (Data Collection Only) has 7 clinical trials on record, with 7 currently active. Their work covers Primary Extra-cranial Solid Tumor, Recurrent or Refractory Glypican 3 (GPC3), T-cell Lymphoma.

Is Dana Farber Cancer Institute (Data Collection Only) accredited by Crixeo Health?

Dana Farber Cancer Institute (Data Collection Only) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute (Data Collection Only)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.